常山药业最新股东户数环比下降6.91%

Core Viewpoint - Changshan Pharmaceutical has experienced a continuous decline in the number of shareholders, indicating potential concerns regarding investor confidence and company performance [2] Shareholder Information - As of December 10, the number of shareholders for Changshan Pharmaceutical was 41,446, a decrease of 3,075 from the previous period (November 30), representing a decline of 6.91% [2] - This marks the third consecutive period of decline in the number of shareholders [2] Stock Performance - The closing price of Changshan Pharmaceutical was 68.32 yuan, reflecting an increase of 1.99% [2] - Since the concentration of shares began, the stock price has cumulatively increased by 9.93% [2] - The stock experienced 5 days of increases and 4 days of decreases during the reporting period [2] Financial Performance - For the first three quarters, the company reported total operating revenue of 681 million yuan, a year-on-year decrease of 13.11% [2] - The net profit for the same period was -44.82 million yuan, representing a significant year-on-year decline of 714.77% [2] - The basic earnings per share were reported at -0.0500 yuan [2]